The Penny Stocks to Watch

SDIX announces multi-year collaboration with Banyan Biomarkers

SDIX announces multi-year collaboration with Banyan Biomarkers
SDIX, today announced a multi-year collaboration with Banyan Biomarkers, Inc. to provide products and services for Banyan’s biomarker discovery work in the detection of traumatic brain injury.
Read more on News-Medical-Net

TSX edges up on rising commodities
The Toronto Stock Exchange reversed earlier losses on Tuesday and was showing a small gain by midday, largely on the strength of commodity stocks
Read more on National Post

Seattle Genetics, Agensys commence ASG-5ME ADC phase I clinical trial for metastatic pancreatic cancer
Seattle Genetics, Inc. and Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., today announced that they have initiated a phase I clinical trial of ASG-5ME for the treatment of metastatic pancreatic cancer. ASG-5ME is an antibody-drug conjugate (ADC) that is being co-developed by both companies for the treatment of solid tumors.
Read more on News-Medical-Net